Regulation of Tumor Cell Motility by ERK Mitogen‐Activated Protein Kinases
- 1 December 2004
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1030 (1) , 208-218
- https://doi.org/10.1196/annals.1329.027
Abstract
International audienceMetastasis is the main cause of human cancer deaths, and cell motility is one key component of the process of metastasis. The ERK mitogen-activated protein kinase (MAPK) signaling pathway is probably one of the most commonly activated in malignant human cancers. We describe the molecular mechanisms by which ERK MAPK signaling regulates cell motility and its importance for cancer cell disseminationKeywords
This publication has 71 references indexed in Scilit:
- FAK–Src signalling through paxillin, ERK and MLCK regulates adhesion disassemblyNature Cell Biology, 2004
- Regulation of Cell Polarity and Protrusion Formation by Targeting RhoA for DegradationScience, 2003
- Tumour-cell invasion and migration: diversity and escape mechanismsNature Reviews Cancer, 2003
- Mutations of the BRAF gene in human cancerNature, 2002
- A fluorescent resonant energy transfer–based biosensor reveals transient and regional myosin light chain kinase activation in lamella and cleavage furrowsThe Journal of cell biology, 2002
- p130Cas, an Assembling Molecule of Actin Filaments, Promotes Cell Movement, Cell Migration, and Cell Spreading in FibroblastsBiochemical and Biophysical Research Communications, 1999
- Src family kinases are required for integrin but not PDGFR signal transductionThe EMBO Journal, 1999
- Neoplastic transformation of rat thyroid cells requires the junB and fra-1 gene induction which is dependent on the HMGI-C gene productThe EMBO Journal, 1997
- Transformation by ras modifies AP1 composition and activityOncogene, 1997
- Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient miceNature, 1995